Supportive Care in Cancer

, Volume 21, Issue 9, pp 2485–2490 | Cite as

Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

  • Maria I. LapidEmail author
  • Pamela J. Atherton
  • Simon Kung
  • Andrea L. Cheville
  • Molly McNiven
  • Jeff A. Sloan
  • Matthew M. Clark
  • Teresa A. Rummans
Original Article



Cancer treatment can profoundly impact the patient’s quality of life (QOL). It has been well documented that there are gender differences in the symptoms associated with cancer treatment. This study explores the impact of gender on QOL for patients with newly diagnosed advanced cancer.


A randomized, controlled clinical trial in patients receiving radiotherapy for advanced cancer demonstrated maintenance of QOL with a six session multidisciplinary structured intervention compared to controls. This current study reports the gender differences in that trial. Outcome measures included the functional assessment of cancer therapy-general (FACT-G), linear analog self-assessment (LASA), and profile of mood states (POMS) at baseline and weeks 4, 27, and 52. Kruskal–Wallis was used to compare QOL scores.


One hundred thirty-one patients (45 women and 86 men, mean age 58.7) participated in the clinical trial. At week 4 postintervention, women in the intervention group had statistically significant improvement in their FACT-G score, FACT-G physical well-being subscale, LASA fatigue, POMS total score, POMS fatigue–inertia subscale, and POMS confusion–bewilderment subscale (p < 0.05). Men receiving the intervention had a smaller decrease in FACT-G score compared to controls (p = 0.048) and also worsened on the LASA financial (p = 0.02). At week 27, the only gender difference was that intervention group men had more POMS anger–hostility (p = 0.009). By week 52, there were no statistically significant gender differences in any of the QOL measures.


Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, suggesting that early interventions can be tailored for each gender.


Oncology Women Men Well-being Psychosocial Radiation therapy 


Funding source

Linse Bock Foundation and the Saint Mary’s Hospital Sponsorship Board

Role of funding source

Not involved in the development or conduct of the study.


  1. 1.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106–130CrossRefGoogle Scholar
  2. 2.
    Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, Johnson ME, Gamble G, Richardson J, Brown P, Martensen J, Miller J, Piderman K, Huschka M, Girardi J, Hanson J (2006) Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol 24(4):635–642. doi: 10.1200/JCO.2006.06.209 CrossRefGoogle Scholar
  3. 3.
    Clark MM, Rummans TA, Atherton PJ, Cheville AL, Johnson ME, Frost MH, Miller JJ, Sloan JA, Graszer KM, Haas JG, Hanson JM, Garces YI, Piderman KM, Lapid MI, Netzel PJ, Richardson JW, Brown PD (2012) Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer. Cancer. doi: 10.1002/cncr.27776 CrossRefGoogle Scholar
  4. 4.
    Cheung WY, Le LW, Gagliese L, Zimmermann C (2011) Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer. Support Care Cancer 19(3):417–423. doi: 10.1007/s00520-010-0865-2 CrossRefGoogle Scholar
  5. 5.
    Kroenke K, Spitzer RL (1998) Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 60(2):150–155CrossRefGoogle Scholar
  6. 6.
    Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579CrossRefGoogle Scholar
  7. 7.
    Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79. doi: 10.1186/1477-7525-1-79 CrossRefGoogle Scholar
  8. 8.
    Winstead-Fry P, Schultz A (1997) Psychometric analysis of the functional assessment of cancer therapy-general (FACT-G) scale in a rural sample. Cancer 79(12):2446–2452CrossRefGoogle Scholar
  9. 9.
    Bretscher M, Rummans T, Sloan J, Kaur J, Bartlett A, Borkenhagen L, Loprinzi C (1999) Quality of life in hospice patients. A pilot study Psychosomatics 40(4):309–313. doi: 10.1016/S0033-3182(99)71224-7 CrossRefGoogle Scholar
  10. 10.
    Locke DE, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, Rummans TA, Ballman KV, Schaefer PL, Buckner JC (2007) Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage 34(6):628–638. doi: 10.1016/j.jpainsymman.2007.01.016 CrossRefGoogle Scholar
  11. 11.
    McNair D, Lorr M, Dropplemen L (1971) Profile of mood states. Educational and Industrial Testing Services, San DiegoGoogle Scholar
  12. 12.
    Curran SL, Andrykowski MA, Studts JL (1995) Short form of the profile of mood states (POMS-SF): psychometric information. Psychol Assess 7(1):4CrossRefGoogle Scholar
  13. 13.
    Thome B, Hallberg IR (2004) Quality of life in older people with cancer—a gender perspective. Eur J Cancer Care (Engl) 13(5):454–463. doi: 10.1111/j.1365-2354.2004.00471.x CrossRefGoogle Scholar
  14. 14.
    Vrettos I, Kamposioras K, Kontodimopoulos N, Pappa E, Georgiadou E, Haritos D, Papadopoulos AA, Niakas D (2012) Comparing health-related quality of life of cancer patients under chemotherapy and of their caregivers. ScientificWorldJournal 2012:135283. doi: 10.1100/2012/135283 CrossRefGoogle Scholar
  15. 15.
    Zimmermann C, Burman D, Swami N, Krzyzanowska MK, Leighl N, Moore M, Rodin G, Tannock I (2011) Determinants of quality of life in patients with advanced cancer. Support Care Cancer 19(5):621–629. doi: 10.1007/s00520-010-0866-1 CrossRefGoogle Scholar
  16. 16.
    Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T (2001) Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant 28(5):503–509. doi: 10.1038/sj.bmt.1703158 CrossRefGoogle Scholar
  17. 17.
    Schmidt CE, Bestmann B, Kuchler T, Longo WE, Rohde V, Kremer B (2005) Gender differences in quality of life of patients with rectal cancer. A five-year prospective study. World J Surg 29(12):1630–1641. doi: 10.1007/s00268-005-0067-0 CrossRefGoogle Scholar
  18. 18.
    Zutshi M, Hull T, Shedda S, Lavery I, Hammel J (2013) Gender differences in mortality, quality of life and function after restorative procedures for rectal cancer. Colorectal Dis 15(1):66–73. doi: 10.1111/j.1463-1318.2012.03075.x CrossRefGoogle Scholar
  19. 19.
    Chambers SK, Newton RU, Girgis A, Nielsen L, Lepore S, Mihalopoulos C, Gardiner R, Galvao DA, Occhipinti S (2011) Living with prostate cancer: randomized controlled trial of a multimodal supportive care intervention for men with prostate cancer. BMC Cancer 11:317. doi: 10.1186/1471-2407-11-317 CrossRefGoogle Scholar
  20. 20.
    Fors EA, Bertheussen GF, Thune I, Juvet LK, Elvsaas IK, Oldervoll L, Anker G, Falkmer U, Lundgren S, Leivseth G (2011) Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review. Psychooncology 20(9):909–918. doi: 10.1002/pon.1844 PubMedGoogle Scholar
  21. 21.
    Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, Lorusso P, Hayes DF, Hussain M, Ruckdeschel J, Fendrick AM, Trask PC, Ronis DL, Kershaw T (2012) Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology. doi: 10.1002/pon.3036 CrossRefGoogle Scholar
  22. 22.
    Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D (2006) The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer 14(10):988–998. doi: 10.1007/s00520-006-0085-y CrossRefGoogle Scholar
  23. 23.
    Hann D, Baker F, Denniston M, Gesme D, Reding D, Flynn T, Kennedy J, Kieltyka RL (2002) The influence of social support on depressive symptoms in cancer patients: age and gender differences. J Psychosom Res 52(5):279–283CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Maria I. Lapid
    • 1
    Email author
  • Pamela J. Atherton
    • 2
  • Simon Kung
    • 1
  • Andrea L. Cheville
    • 3
  • Molly McNiven
    • 4
  • Jeff A. Sloan
    • 2
  • Matthew M. Clark
    • 1
  • Teresa A. Rummans
    • 1
  1. 1.Department of Psychiatry and PsychologyMayo ClinicRochesterUSA
  2. 2.Department of Health Sciences ResearchMayo ClinicRochesterUSA
  3. 3.Department of Physical Medicine and RehabilitationMayo ClinicRochesterUSA
  4. 4.Graduate School Student Interim ProgramMayo ClinicRochesterUSA

Personalised recommendations